MANE - Veradermics, Incorporated
Veradermics, Incorporated functions as a biopharmaceutical enterprise focused on devising pioneering therapeutic interventions for various skin and cosmetic disorders. The company's development pipeline includes treatments for Pattern Hair Loss (PHL), impacting both adult and pediatric demographics. A flagship offering is VDPHL01, an orally administered, non-hormonal medication specifically for chronic hair loss management in both male and female patients with PHL.
As of Sep 30, 2026: spot at $122.18, ATM IV 114.1%, max pain $110.00, net GEX -$149.9K.
- Sector
- Healthcare
- Industry
- Biotechnology
- Market Cap
- $5.06B
- Beta
- 1.23
- 52-Week Range
- 32-131.24
- CEO
- Reid Waldman
- Employees
- 37
- IPO Date
- Feb 4, 2026
- Exchange
- NYSE
What MANE Looks Like to Options Traders Today
negative net gamma exposure (-$149.9K) means dealers hedge with trend, amplifying realized volatility and accelerating directional moves; the 25-delta skew (0.116) prices calls richer than puts, often reflecting upside speculation or squeeze risk.
What This Page Covers
The MANE overview links into per-metric analysis views: max pain, gamma exposure, volatility skew, expected move, options chain, open interest history, and aggregate Greeks. Microstructure data is available on short interest, short volume, fail-to-deliver, and market structure. Corporate data is on fundamentals, earnings, analyst ratings, and insider trading.
Frequently asked MANE overview questions
- What is MANE?
- MANE is the ticker symbol for Veradermics, Incorporated, a listed security. Veradermics, Incorporated functions as a biopharmaceutical enterprise focused on devising pioneering therapeutic interventions for various skin and cosmetic disorders. The company's development pipeline includes treatments for Pattern Hair Loss (PHL), impacting both adult and pediatric demographics. Listed on NYSE. MANE is the equity ticker shown on this page; equity options traders use the security for directional, volatility, and income strategies via the listed options chain.
- What does the MANE options snapshot look like today?
- As of Sep 30, 2026, the MANE options snapshot shows spot at $122.18, ATM IV 114.1%, max pain $110.00, net GEX -$149.9K, expected move 32.71%. The full options chain, Greeks by strike and expiration, per-strike open-interest distribution, dealer gamma and delta exposure, and the volatility skew surface are linked from this overview page. Each per-metric route refreshes once per trading session and reflects the most recent close-of-business listed-options state.
- What are MANE's key statistics?
- Veradermics, Incorporated (MANE) carries a market capitalization of $5.06B, beta of 1.23 relative to the broader market, 52-week range of 32-131.24. Full income statement, balance sheet, cash flow, and TTM ratio history is on the per-ticker fundamentals page; daily price history and 52-week levels are accessible from the same view. These structural inputs frame how the options market prices implied volatility around earnings windows and capital events.
- What sector or industry does MANE belong to?
- Veradermics, Incorporated operates in the Healthcare sector, in the Biotechnology industry. Sector classification affects how the ticker correlates with sector ETFs, how it reacts to macro factors like rate moves and commodity prices, and how its options pricing compares to sector peers. Compare MANE's implied volatility and skew against sector benchmarks to gauge whether the options market is pricing single-name or systemic risk relative to the broader peer group.
- How current is the MANE data on this page?
- The options snapshot above is dated Sep 30, 2026 and refreshes once per session, with all per-strike Greeks and exposure aggregates recomputed at the daily close. Company-profile fields (sector, industry, market cap, P/E, IPO date) refresh from the vendor feed nightly. Financials and earnings refresh as 10-K and 10-Q filings are parsed (typically within several business days of the actual report). FINRA microstructure data refreshes on the source's cadence (daily for short volume, bi-monthly for short interest, weekly for the OTC volume file, twice-monthly for SEC FTD).